The Prostate cancer Intervention Versus Observation Trial (PIVOT) study, which randomised men diagnosed during the early PSA screening era between watchful waiting and radical surgery, suggests that men with low-risk localised prostate cancer have no benefit from treatment with regards to prostate cancer-specific mortality [13]. The gene discussed is KLK3; the disease is Familial prostate cancer.